Zurcher Kantonalbank Zurich Cantonalbank Boosts Stake in Humana Inc. (NYSE:HUM)

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Humana Inc. (NYSE:HUM) by 2.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,880 shares of the insurance provider’s stock after buying an additional 1,237 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Humana were worth $21,004,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Everence Capital Management Inc. lifted its stake in shares of Humana by 4.0% during the 4th quarter. Everence Capital Management Inc. now owns 4,370 shares of the insurance provider’s stock worth $2,001,000 after purchasing an additional 170 shares during the period. DGS Capital Management LLC boosted its holdings in shares of Humana by 7.9% during the fourth quarter. DGS Capital Management LLC now owns 681 shares of the insurance provider’s stock worth $312,000 after purchasing an additional 50 shares during the last quarter. SVB Wealth LLC boosted its holdings in shares of Humana by 10.4% during the fourth quarter. SVB Wealth LLC now owns 1,475 shares of the insurance provider’s stock worth $675,000 after purchasing an additional 139 shares during the last quarter. Emfo LLC acquired a new stake in shares of Humana during the fourth quarter worth $687,000. Finally, Mackenzie Financial Corp boosted its holdings in shares of Humana by 75.7% during the fourth quarter. Mackenzie Financial Corp now owns 121,746 shares of the insurance provider’s stock worth $55,737,000 after purchasing an additional 52,469 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita bought 545 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were acquired at an average cost of $367.09 per share, with a total value of $200,064.05. Following the completion of the transaction, the director now owns 2,578 shares in the company, valued at $946,358.02. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the topic of several analyst reports. TheStreet cut Humana from a “b” rating to a “c+” rating in a report on Monday, January 8th. Deutsche Bank Aktiengesellschaft cut Humana from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $595.00 to $360.00 in a report on Thursday, January 25th. Argus cut Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $391.00 target price on shares of Humana in a report on Wednesday, April 10th. Finally, Wells Fargo & Company reduced their target price on Humana from $413.00 to $350.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. Eleven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, Humana currently has an average rating of “Hold” and a consensus price target of $465.42.

Humana Trading Up 1.9 %

NYSE:HUM opened at $323.46 on Thursday. The business’s 50-day moving average is $344.41 and its two-hundred day moving average is $425.71. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.59. Humana Inc. has a 12 month low of $299.23 and a 12 month high of $541.21. The firm has a market capitalization of $39.03 billion, a PE ratio of 16.32, a price-to-earnings-growth ratio of 1.86 and a beta of 0.45.

Humana (NYSE:HUM) last released its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a net margin of 2.34% and a return on equity of 19.44%. The company had revenue of $26.46 billion during the quarter, compared to analysts’ expectations of $25.47 billion. During the same period last year, the business earned $1.62 earnings per share. The company’s revenue for the quarter was up 17.9% compared to the same quarter last year. Research analysts predict that Humana Inc. will post 16.06 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.09%. Humana’s payout ratio is 17.86%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.